Fibrogen share price today

(FGEN)

Fibrogen share price is $0.5 & ₹42.60 as on 25 Dec 2024, 2.30 'hrs' IST

$0.5

▲

0.02

(3.88%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Fibrogen share price in Dollar and Rupees. Guide to invest in Fibrogen from India. Also see the sentimental analysis on Indian investors investing in Fibrogen. Get details on the Indian mutual funds that are investing in Fibrogen. Get Analyst recommendations and forecasts along with all the Fibrogen's financials.

Fibrogen share price movements

Today's Low: $0.48
Today's High: $0.55
$0.50
3.78%
Downside
Day's Volatility :12.88%
Upside
9.45%
52 Weeks Low: $0.18
52 Weeks High: $2.93
$0.50
64.0%
Downside
52 Weeks Volatility :93.86%
Upside
82.94%

Fibrogen Returns

Period	Fibrogen Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	27.32%	-9.0%	0.0%
6 Months	-51.59%	-4.6%	0.0%
1 Year	-38.38%	3.0%	0.0%
3 Years	-96.65%	0.0%	-21.1%

Fibrogen Key Statistics

in dollars & INR

Previous Close	$0.48
Open	$0.5
Today's High	$0.5522
Today's Low	$0.4811
Market Capitalization	$50.2M
Today's Volume	$2.2M
52 Week High	$2.93
52 Week Low	$0.18
Revenue TTM	$173.8M
EBITDA	$-165.8M
Earnings Per Share (EPS)	$-1.23
Profit Margin	-96.84%
Quarterly Earnings Growth YOY	0.54%
Return On Equity TTM	-1015.79%

How to invest in Fibrogen from India?

It is very easy for Indian residents to invest directly in Fibrogen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fibrogen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fibrogen or FGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fibrogen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fibrogen shares which would translate to 1.704 fractional shares of Fibrogen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Fibrogen, in just a few clicks!

Returns in Fibrogen for Indian investors in Rupees

Investment Value

₹1,00,000

Fibrogen investment value today

Current value as on today

₹63,967

Returns

₹36,033

(-36.03%)

Returns from Fibrogen Stock

₹38,272 (-38.27%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Fibrogen

16%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Fibrogen on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 16% more investors are searching Fibrogen in the last 30 days versus the previous period.

Global Institutional Holdings in Fibrogen

PRIMECAP Management Company
9.84%
Armistice Capital, LLC
6.75%
Vanguard Group Inc
5.84%
BlackRock Inc
2.39%
683 Capital Management LLC
2.12%
Jacobs Levy Equity Management, Inc.
2.09%

Analyst Recommendation on Fibrogen

Sell

0%Buy

37%Hold

62%Sell

Based on 8 Wall street analysts offering stock ratings for Fibrogen(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Fibrogen

What analysts predicted

Upside of 1900.0%

Current:

$0.50

Target:

$10.00

Insights on Fibrogen

Price Movement
In the last 7 days, FGEN stock has moved up by 41.0%
Decreasing Revenue
Revenue is down for the last 3 quarters, 55.90M → 46.33M (in $), with an average decrease of 9.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.54M → -17.08M (in $), with an average decrease of 9.9% per quarter
FGEN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 64.8%
FGEN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 122.0%
Price to Sales
ForFGEN every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Fibrogen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$213.0M	↑ 69.46%
Net Income	$-86.4M	↓ 31.52%
Net Profit Margin	-40.58%	↑ 59.85%

	FY19	Y/Y Change
Revenue	$256.6M	↑ 20.48%
Net Income	$-77.0M	↓ 10.93%
Net Profit Margin	-30.0%	↑ 10.58%

	FY20	Y/Y Change
Revenue	$176.3M	↓ 31.28%
Net Income	$-189.3M	↑ 145.93%
Net Profit Margin	-107.36%	↓ 77.36%

	FY21	Y/Y Change
Revenue	$235.3M	↑ 33.46%
Net Income	$-291.0M	↑ 53.75%
Net Profit Margin	-123.68%	↓ 16.32%

	FY22	Y/Y Change
Revenue	$140.7M	↓ 40.19%
Net Income	$-295.2M	↑ 1.44%
Net Profit Margin	-209.78%	↓ 86.1%

	FY23	Y/Y Change
Revenue	$147.8M	↑ 4.99%
Net Income	$-284.2M	↓ 3.72%
Net Profit Margin	-192.37%	↑ 17.41%

	Q2 FY23	Q/Q Change
Revenue	$44.3M	↑ 22.56%
Net Income	$-87.7M	↑ 13.13%
Net Profit Margin	-197.84%	↑ 16.48%

	Q3 FY23	Q/Q Change
Revenue	$40.1M	↓ 9.44%
Net Income	$-63.6M	↓ 27.45%
Net Profit Margin	-158.51%	↑ 39.33%

	Q4 FY23	Q/Q Change
Revenue	$27.1M	↓ 32.38%
Net Income	$-56.2M	↓ 11.61%
Net Profit Margin	-207.21%	↓ 48.7%

	Q1 FY24	Q/Q Change
Revenue	$55.9M	↑ 105.99%
Net Income	$-32.9M	↓ 41.43%
Net Profit Margin	-58.91%	↑ 148.3%

	Q2 FY24	Q/Q Change
Revenue	$50.6M	↓ 9.41%
Net Income	$-15.5M	↓ 52.8%
Net Profit Margin	-30.69%	↑ 28.22%

	Q3 FY24	Q/Q Change
Revenue	$46.3M	↓ 8.51%
Net Income	$-17.1M	↑ 9.91%
Net Profit Margin	-36.87%	↓ 6.18%

	FY18	Y/Y Change
Profit	$213.0M	↑ 69.46%

	FY19	Y/Y Change
Profit	$255.4M	↑ 19.94%

	FY20	Y/Y Change
Profit	$167.5M	↓ 34.44%

	FY21	Y/Y Change
Profit	$222.4M	↑ 32.84%

	FY22	Y/Y Change
Profit	$120.5M	↓ 45.85%

	FY23	Y/Y Change
Profit	$128.9M	↑ 7.02%

	Q2 FY23	Q/Q Change
Profit	$38.6M	↑ 18.18%

	Q3 FY23	Q/Q Change
Profit	$35.9M	↓ 7.04%

	Q4 FY23	Q/Q Change
Profit	$21.7M	↓ 39.45%

	Q1 FY24	Q/Q Change
Profit	$30.1M	↑ 38.74%

	Q2 FY24	Q/Q Change
Profit	$45.5M	↑ 50.79%

	Q3 FY24	Q/Q Change
Profit	$41.0M	↓ 9.73%

	FY18	Y/Y Change
Operating Cash Flow	$-76.1M	↑ 14.48%
Investing Cash Flow	$-522.1M	↓ 847.32%
Financing Cash Flow	$13.9M	↓ 97.21%

	FY19	Y/Y Change
Operating Cash Flow	$-78.7M	↑ 3.36%
Investing Cash Flow	$120.0M	↓ 122.99%
Financing Cash Flow	$-4.3M	↓ 130.99%

	FY20	Y/Y Change
Operating Cash Flow	$81.6M	↓ 203.68%
Investing Cash Flow	$452.5M	↑ 277.02%
Financing Cash Flow	$13.3M	↓ 410.3%

	FY21	Y/Y Change
Operating Cash Flow	$-82.2M	↓ 200.77%
Investing Cash Flow	$-427.0M	↓ 194.36%
Financing Cash Flow	$-563.0K	↓ 104.22%

	FY22	Y/Y Change
Operating Cash Flow	$-145.9M	↑ 77.46%
Investing Cash Flow	$89.1M	↓ 120.87%
Financing Cash Flow	$46.8M	↓ 8408.35%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-110.6M	↑ 8.84%
Investing Cash Flow	$-14.3M	↓ 113.8%
Financing Cash Flow	$91.5M	↑ 190.72%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-84.5M	↓ 23.54%
Investing Cash Flow	$54.2M	↓ 479.54%
Financing Cash Flow	$-22.0K	↓ 100.02%

Fibrogen Technicals Summary

Sell

Neutral

Buy

Fibrogen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Fibrogen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fibrogen Inc	28.64%	-51.59%	-38.38%	-96.65%	-98.85%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fibrogen Inc	NA	NA	0.0	-0.86	-10.16	-0.27	NA	-2.07
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fibrogen Inc	Sell	$50.2M	-98.85%	NA	-96.84%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Fibrogen

fibrogen is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. the company has built upon its extensive research experience in fibrosis and hypoxia-inducible factor (hif) biology to generate clinical programs targeting multiple therapeutic areas. fibrogen's most advanced product candidate, roxadustat (fg-4592), is an oral small molecule inhibitor of hif prolyl hydroxylases (hif-phs), in phase 3 clinical development for the treatment of anemia in chronic kidney disease (ckd). our second product candidate, fg-3019, is a monoclonal antibody in phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (ipf), pancreatic cancer and liver fibrosis. for more information please visit: www.fibrogen.com.

Organization	Fibrogen
Employees	486
CEO	Mr. Thane Wettig
Industry	Health Technology

Management People of Fibrogen

Name	Title
Mr. Thane Wettig	CEO & Director
Mr. Juan Graham	Senior VP & CFO
Ms. Christine L. Chung	Senior Vice President of China Operations
Dr. Barry A. Berkowitz Ph.D.	Founder
David DeLucia	Vice President of Corporate FP&A and Investor Relations
Mr. Michael D. Lowenstein J.D., Ph.D.	Chief Legal Officer
Ms. Tricia Stewart	Chief People Officer
Mr. Kirk A. Christoffersen MBA	Chief Business Officer
Dr. Elizabeth Bearby Pharm.D.	Senior VP of Regulatory, Biometrics, Scientific Communications & Clinical Project Management
Mr. Julian N. Stern	Secretary

Important FAQs about investing in Fibrogen from India :

What is Fibrogen share price today?

Fibrogen share price today stands at $0.50, Open: $0.50 ; Previous Close: $0.48 ; High: $0.55 ; Low: $0.48 ; 52 Week High: $2.93 ; 52 Week Low: $0.18. The stock opens at $0.50, after a previous close of $0.48. The stock reached a daily high of $0.55 and a low of $0.48, with a 52-week high of $2.93 and a 52-week low of $0.18.

Can Indians buy Fibrogen shares?

Yes, Indians can invest in the Fibrogen (FGEN) from India.

With INDmoney, you can buy Fibrogen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Fibrogen at zero transaction cost.

How can I buy Fibrogen shares from India?

It is very easy to buy Fibrogen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fibrogen be purchased?

Yes, you can buy fractional shares of Fibrogen with INDmoney app.

What are the documents required to start investing in Fibrogen stocks?

To start investing in Fibrogen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.